McMaster drug trial receives more than $6m to test smallpox vaccine against mpox
Children accounted for the majority of mpox cases and deaths in the DRC since June 2023
Read Moreby Jen Brogan | Aug 15, 2024 | News | 0
Children accounted for the majority of mpox cases and deaths in the DRC since June 2023
Read Moreby Jen Brogan | Jul 17, 2024 | News | 0
The new technology can generate a target infection within 30 minutes to two hours
Read Moreby Jen Brogan | May 17, 2024 | News | 0
Areas include health research across life stages, from paediatrics to health ageing and resilience
Read Moreby Jen Brogan | Apr 12, 2024 | News | 0
Both partners’ will leverage their nuclear research facilities and expertise to develop new health interventions
Read Moreby Jen Brogan | Feb 8, 2024 | News | 0
The cell could be a target for new immunotherapies for the chronic disease
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
